ArticleNano letters2026
Hybrid-2D Excitonic Metasurfaces for Complex Amplitude Modulation.
Article in Nano letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dynamic control of visible light is crucial for technologies such as holographic displays and adaptive optics. Passive metasurfaces can shape wavefronts at the subwavelength scale, and active metasurfaces promise to extend this functionality into the temporal domain. However, existing metasurfaces for dynamic phase manipulation typically cannot deliver phase modulation across a broad range without causing variations in the scattering amplitude. Here, we use an inverse-design pipeline to numerically demonstrate a hybrid-2D excitonic metasurface platform offering independent amplitude and phase control in the visible regime. Harnessing the gate-tunable excitonic response of monolayer WS
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.